Year: 2022

With 23.8% CAGR, Teleradiology Market Size Hit USD 65.21 Billion in 2026

Written by Customer Service on December 6, 2022. Posted in Mergers And Acquisitions.

According to Fortune Business Insights, The global teleradiology market size is predicted to reach USD 65.21 billion by 2026, exhibiting a CAGR of 23.8% during the forecast period. the market size stood at USD 11.84 billion in 2018. Pune, India, Dec. 06, 2022 (GLOBE NEWSWIRE) — The global teleradiology market size is predicted to reach USD 65.21 billion by 2026, exhibiting a CAGR of 23.8% during the forecast period. The rising number of imaging procedures by radiologists will contribute positively to the growth of the market. Moreover, the necessity to lower cost of radiological images for interpretation will spur business opportunities for the teleradiology market in the forthcoming years. In addition, the growing accessibility of radiology equipment for patients will boost the teleradiology market trends in the foreseeable future,...

Reliq Health Technologies, Inc. Announces 35 New Skilled Nursing Facilities Clients in Florida

Written by Customer Service on December 6, 2022. Posted in Public Companies.

HAMILTON, Ontario, Dec. 06, 2022 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that a previously disclosed client with a network of Skilled Nursing Facilities (SNFs) in Florida has added an additional 35 facilities to its contract with the Company. This addition to the existing contract is expected to add a further 3,500 new patients per month or 42,000 new patients per year to Reliq’s iUGO Care platform beginning in 2023. “We are very pleased that our existing client has chosen to expand the deployment of our iUGO Care platform into an additional 35 of the Skilled Nursing Facilities (SNFs) in their...

Zscaler Study Finds 90% of Global Enterprises are Adopting Zero Trust, Yet Have Not Unlocked the Full Business Potential

Written by Customer Service on December 6, 2022. Posted in Public Companies.

More than 90% of organizations migrating to the cloud have implemented, are implementing, or are in the process to implement a zero trust architecture Only 22% of global IT decision-makers claim to be ‘fully confident’ their organization is leveraging the potential of their cloud infrastructure, presenting an opportunity for zero trust 68% agree that secure cloud transformation is not possible with legacy network security infrastructures or that Zero Trust Network Access (ZTNA) has clear advantages over legacy firewalls and VPNs ZTNA is the top priority for zero trust investments over the next 12 months – indicating the importance of remote access for the hybrid workplaceSAN JOSE, Calif, Dec. 06, 2022 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, found that more than 90% of IT leaders who have...

Mainz Biomed Announces IRB Approval and Initiation of US Pivotal FDA Clinical Study

Written by Customer Service on December 6, 2022. Posted in Public Companies.

ReconAAsense study examining the clinical performance of mRNA and DNA test combined with a fecal immunochemical test for early detection of advanced adenoma and colorectal cancer to enroll 15,000 subjects across the United States, results expected in 2025 Aims to enhance technical profile of the Mainz Biomed test to identify advanced adenomas (AA), a type of pre-cancerous polyp that can lead to colorectal cancer (CRC) Study will form the basis of the data package for review by the U.S. Food and Drug Administration (FDA) to achieve marketing authorizationBERKELEY, Calif. and MAINZ, Germany, Dec. 06, 2022 (GLOBE NEWSWIRE) — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that it has received approval from an...

RECHARGE RESOURCES INTERCEPTS FIRST LITHIUM BRINE AQUIFER IN WELL 1 AT POCITOS 1 LITHIUM SALAR

Written by Customer Service on December 6, 2022. Posted in Public Companies.

Vancouver, BC, Dec. 06, 2022 (GLOBE NEWSWIRE) — Recharge Resources Ltd. (“Recharge” or the “Company”) (RR: CSE) (RECHF: OTC) (SL50: Frankfurt) is pleased to announce the Company has intercepted an aquifer that surged at 325m depth in its NQ diameter exploration well at its ongoing production diameter well drill program at the “Pocitos 1” Salar Lithium Brine Project in Salta, Argentina. Drilling will continue through the target production zones down to 425 meters. This is another planned milestone in Recharge’s endeavour to establish a NI 43-101 compliant resource and build up to a 20,000 tonne per year EkoSolve™ lithium extraction plant at Pocitos 1 in order to supply Richlink Capital Pty Ltd clients up to 20,000 tonnes of lithium per year as previously announced under a letter of intent and framework agreement. Lithium...

Disclosure of Voting Rights in IDEX Biometrics Chair Morten Opstad – 06 December 2022

Written by Customer Service on December 6, 2022. Posted in Public Companies.

At the close of business on 05 December 2022, Morten Opstad, Chair of the Board of IDEX Biometrics ASA, held the following voting rights in IDEX, for the purpose of the Extraordinary General Meeting on 09 December 2022: Total 238,903,559 shares or 21,38% of the share capital and votes, consisting of the following:Proxy to represent and vote for 70,224,923 shares or 6,29% of the share capital, including shares held by Mr Opstad and close relations Proxy with voting instructions for 168,678,636 shares or 15,1% of the share capital.For further information contact: Marianne Bøe, Head of Investor Relations E-mail: marianne.boe@idexbiometrics.com Tel: + 47 918 00186 About IDEX Biometrics IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure and personal...

Share buybacks in Spar Nord Bank – transactions in week 48

Written by Customer Service on December 6, 2022. Posted in Public Companies.

Company announcement no. 48In company announcement no. 9 2022, Spar Nord announced a share buyback programme of up to DKK 225 million. The share buyback was initiated on 15 June 2022. The purpose of the share buyback is to reduce the bank’s share capital by the shares acquired under the programme, and the programme is executed pursuant to Regulation (EU) No 596/2014 of 16 April 2014 (“Market Abuse Regulation”). In week 48, the following transactions were made under the share buyback programme. Number of shares Average purchase price Transaction value (DKK)Accumulated from last announcement 2,023,500 170,807,14228 Novemberr 2022 10,000 101.67 1,016,70029 November 2022 10,000 103.30 1,033,00030 November 2022 9,000 104.15 937,35001 December 2022 8,000 105.21 841,68002 December 2022 9,000 103.43 930,870Total...

Nidec to Establish a Joint Venture with FREYR Battery, a Semi-Solid Lithium-Ion Battery Manufacturer

Written by Customer Service on December 6, 2022. Posted in Public Companies.

KYOTO, Japan, Dec. 06, 2022 (GLOBE NEWSWIRE) — Nidec Corporation (“Nidec” or the “Company”) (TSE: 6594; OTC US: NJDCY) announced today that the Company has completed the establishment procedures for the joint venture agreement with FREYR Battery (“FREYR”), a developer of clean, next-generation battery cell production capacity, as previously disclosed on August 30, 2022. 1. Overview of the joint venture to be established(1) Company name Nidec Energy AS(2) Head office/development base Oslo, Norway(3) Production base Mo i Rana, Norway(4) CEO Dominique Llonch*(5) Date of establishment *Appointed by Nidec Group(6) Main Business December 6, 2022 Development, manufacturing and sales of battery modules and packs for Battery Energy Storage Solution (BESS) or applications(7) Number of employees More...

AS Tallink Grupp Reporting Calendar 2023

Written by Customer Service on December 6, 2022. Posted in Public Companies.

3 January December traffic volumes3 February January traffic volumes22 February Unaudited 12-months interim report3 March February traffic volumes4 April March traffic volumes27 April Unaudited 3-months interim report3 May April traffic volumes5 June May traffic volumes4 July June traffic volumes27 July Unaudited 6-months interim report3 August July traffic volumes5 September August traffic volumes3 October September traffic volumes26 October Unaudited 9-months interim report3 November October traffic volumes5 December November traffic volumesAnneli Simm Investor Relations Coordinator AS Tallink Grupp Sadama 5 10111 Tallinn, Estonia E-mail: anneli.simm@tallink.ee

OKYO Pharma Limited (“OKYO” or the “Company”) – OKYO publicly files a registration statement with the SEC

Written by Customer Service on December 6, 2022. Posted in Public Companies.

LONDON and NEW YORK, Dec. 06, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to address the significant unmet need in the multi-billion-dollar market, announces, that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (“SEC“) relating to a secondary public offering of its American Depositary Shares (“ADSs“), each of which will represent 65 of the Company’s ordinary shares of no par value each (“Ordinary Shares“) in the United States (the “Offering“). All ADSs to be sold in the Offering will be offered by OKYO. The number of ADSs to be offered and the price range for the Offering have not yet been determined....

Year: 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals